31 August 2022>: Clinical Research
Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Patients Receiving 4–6 Cycles of Platinum-Based and Taxane-Based Chemotherapy: A Prospective, Single-Center Study from Kosovo
Blerim Myftiu 12ABCDEFG* , Zylfije Hundozi 12ACDF , Faton Sermaxhaj 3ABD , Afrim Blyta 1ACDF , Nexhmedin Shala 12CD , Fisnik Jashari 12C , Hasime Qorraj Bytyqi 4CDF , Ekrem Hyseni 3BC , Ilir Kurtishi 3BCDOI: 10.12659/MSM.937856
Med Sci Monit 2022; 28:e937856
Table 3 Chemotherapy protocols based on platinum- and taxane-based compounds.
Treatment regimen based on Platinum and/or Taxane | Number | Age (Mean±SD) |
---|---|---|
Neither platinum nor taxane | 8 | 56.7±15.8 |
Platinum only and/or combination | 60 | 60±10.1 |
Taxane only and/or combination | 30 | 56.7±11.8 |
Platinum + Taxane and/or combination | 22 | 62±10.3 |
SD – standard deviation. |